We have located links that may give you full text access.
Synthesis of Biogenic Copper Nanoparticles Embedded in Graphene Oxide-Chitosan Composite and Its Anti-Bacterial and Cytotoxic Activities.
Journal of Nanoscience and Nanotechnology 2019 May 2
In the current scenario, nanoparticle synthesis has been fascinated by biogenic approaches than the chemical methods. However, reproducibility of the source stands essentially in nanoparticle synthesis. Nanoparticle synthesis by fungi has more advantages such as the potential for bioaccumulation, immunity towards toxicity, relatively easier to handle, simpler in synthesis and downstream processing. In this study, biogenic copper nanoparticles (CuNPs) were embedded within graphene oxide-chitosan (GO-CS) polymer to endure the biocompatibility and toxicological effects on both normal and cancer cells. The characteristics of the copper nanoparticles/graphene oxide-chitosan (CuNPs/GO-CS) nanocomposites was found to be superior to the GO-CS. This is evident from the results obtained from X-ray diffraction technique, UV-visible spectroscopy, atomic force microscope, fourier transform infrared spectroscopy, fluorescence spectroscopy, confocal laser scanning microscope and scanning electron microscopy. The synthesized new copper nanoparticles/graphene oxide-chitosan (CuNPs/GO-CS) nanocomposites were studied for their anti-bacterial activity against Escherichia coli MTCC 443 and anti-cancer activity on breast cancer MCF7 cell lines.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app